Issue 5, 2024

Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Abstract

Correction for ‘Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer’ by Yuejie Zhu et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d3md00752a.

Associated articles

Article information

Article type
Correction
Submitted
28 Mar 2024
Accepted
28 Mar 2024
First published
15 Apr 2024
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2024,15, 1782-1782

Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer

Y. Zhu, X. Li, Q. Zhang, X. Yang, X. Sun, Y. Pan, X. Yuan, Y. Ma, B. Xu and Z. Yang, RSC Med. Chem., 2024, 15, 1782 DOI: 10.1039/D4MD90013H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements